Walleye Capital
APLT

Walleye Capital’s Applied Therapeutics APLT Stock Holding History

Walleye Capital’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-137,593
Closed -$1.17M – 4813
2024
Q3 		$1.17M Sell
137,593
-264,772
-66% -$1.56M ﹤0.01% 2488
2024
Q2 		$1.88M Buy
402,365
+94,049
+31% +$445K ﹤0.01% 2168
2024
Q1 		$2.1M Buy
308,316
+291,316
+1,714% +$1.31M ﹤0.01% 1966
2023
Q4 		$57K Sell
17,000
-122,381
-88% -$305K ﹤0.01% 4258
2023
Q3 		$347K Buy
+139,381
New +$230K ﹤0.01% 3108
2022
Q2 		– Sell
-52,273
Closed -$110K – 2334
2022
Q1 		$110K Buy
52,273
+41,073
+367% +$110K ﹤0.01% 1718
2021
Q4 		$100K Buy
+11,200
New +$147K ﹤0.01% 1688
2020
Q4 		– Sell
-10,514
Closed -$218K – 928
2020
Q3 		$218K Buy
+10,514
New +$273K 0.02% 588

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Walleye Capital's APLT Position: Q4 2024 in Review

Walleye Capital sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 137,593 shares — an estimated $1.17M sold.

Walleye Capital first reported a position in APLT in Q3 2020 and held it in 8 quarters. The position peaked at $2.1M in Q1 2024. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Walleye Capital reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 137,593 Applied Therapeutics shares in Q4 2024, an estimated $1.17M.
  • Walleye Capital first reported a position in Applied Therapeutics in Q3 2020 and held it in 8 quarters.
  • Walleye Capital's Applied Therapeutics position peaked at $2.1M in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.